Amicus Therapeutics, Inc.

Biotechnology • Healthcare • Princeton, NJ, United States • FOLD (NGM)

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company's commercial product and product candidates consist of Galafold, an orally administered monotherapy for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, a novel two-component treatment program for adults living with late-onset Pompe disease. It has collaboration and license agreement with GlaxoSmithKline to develop and commercialize Galafold. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Stock Performance (90 Days)

Data through Dec 23, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Leerink Partners downgrades Amicus Therapeutics stock on BioMarin acquisition By Investing.com - Investing.com Nigeria

Investing.com Nigeria • Dec 29

Amicus Therapeutics (FOLD) Soars to 52-Week High on ‘Strong Buy’ Reco - Yahoo Finance

Yahoo Finance • Dec 13

BioMarin to buy Amicus Therapeutics for $4.8 billion in rare disease bet - Reuters

Reuters • Dec 19

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

MarketBeat • Dec 31

BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet - CNBC

CNBC • Dec 19

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has AMICUS THERAPEUTICS, INC. had layoffs?

No layoff events have been recorded for AMICUS THERAPEUTICS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does AMICUS THERAPEUTICS, INC. have?

AMICUS THERAPEUTICS, INC. has approximately 499 employees.

What industry is AMICUS THERAPEUTICS, INC. in?

AMICUS THERAPEUTICS, INC. operates in the Biotechnology industry, within the Healthcare sector.

Is AMICUS THERAPEUTICS, INC. a publicly traded company?

Yes, AMICUS THERAPEUTICS, INC. is publicly traded under the ticker symbol FOLD on the NGM. The company has a market capitalization of approximately $4.40 billion.

Where is AMICUS THERAPEUTICS, INC. headquartered?

AMICUS THERAPEUTICS, INC. is headquartered in Princeton, NJ, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.